1. Scrip
  2. >>Leadership

Roche Diagnostics CEO Schinecker Will Succeed Schwan As A New Chapter Unfolds

 
• By Jessica Merrill

The Swiss drug maker is preparing for a smooth transition in 2023, appointing 20-year Roche veteran and diagnostic chief Thomas Schinecker as its next chief executive as Severin Schwan becomes chairman.

turning the page
Roche is transitioning leadership to a new CEO • Source: Shutterstock

Roche Holding AG is planning for a smooth leadership transition in March 2023 when Diagnostic CEO Thomas Schinecker will succeed longtime CEO Severin Schwan, who will step into the role of chairman as current chairman Christoph Franz steps down. The appointment of a leader from Europe and coming out of the diagnostics business is in line with the Swiss company's track record.

The appointment, announced during the firm’s midyear sales and earnings call on 21 July, will put another longtime Roche executive at the helm

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

More from Scrip

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.

Pipeline Watch: Six Approvals And Thirteen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pharma Left Hanging After US/UK Trade Pact

 
• By Kevin Grogan

An ‘historic economic prosperity deal’ does not include the sector.